Suwanee, GA – According to filings with the U.S. Securities and Exchange Commission, Sanuwave Health is raising $24,710,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kevin Richardson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Sanuwave Health

SANUWAVE is a shockwave technology company developing patented, noninvasive devices for the repair and regeneration of skin, musculoskeletal tissue and vascular structures.  Its lead product, the dermaPACE System, is FDA Cleared for the treatment of Diabetic Foot Ulcers (DFU) in the United States. For International Markets, the dermaPACE System is CE Marked for use on acute and chronic defects of the skin and subcutaneous soft tissue.

To learn more about Sanuwave Health, visit http://sanuwave.com/

Contact:
Kevin Richardson, Chief Executive Officer
770-419-7525
kevin.richardson@sanuwave.com
https://www.linkedin.com/in/kevin-a-richardson-ii-4b041949/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved